Recent News and Updates
Ultragenyx letter to the WD community
Read more: WDA Community Update from Ultragenyx Oct 2024 (PDF)
Gene therapy updates from the WDA
Read more: GTx-Updates (PDF)
WDA designates newest Wilson Disease Center of Excellence at University of California, Davis
Read more: https://health.ucdavis.edu/news/headlines/uc-davis-health-designated-wilson-disease-center-of-excellence/2024/09
Vivet Therapeutics Wilson Disease Update April 2024
Dear members of the Wilson disease community, We are pleased to update you on the progress of GATEWAY, the first gene therapy clinical study evaluating the effects of Vivet’s investigational therapy VTX-801, which is [...]
Ultragenyx Wilson Disease Update April 2024
As Ultragenyx continues to advance its research for Wilson disease, please find a status update on the CYPRUS2+ study. The CYPRUS2+ study is designed with three stages. We are currently in Stage 1 where [...]